DHEA supplementation: the claims in perspective.

Deficiency of dehydroepiandrosterone (DHEA) is associated with lupus erythematosus, diabetes mellitus, Alzheimer disease, and some cancers, but we are not yet ready to conclude that prescribing supplemental DHEA is helpful in these or any other conditions. DHEA shows some promise in observational clinical studies and laboratory experiments, but we still need large-scale human studies to answer key questions. For now, we do not have enough evidence to recommend routine treatment with DHEA. As with other supplements, quality control is always a concern, and different brands may contain different amounts of active ingredient.

[1]  N. Martin,et al.  Genetics of serum dehydroepiandrosterone sulfate and its relationship to insulin in a population-based cohort of twin subjects. , 2002, The Journal of clinical endocrinology and metabolism.

[2]  Z. Sadowski,et al.  Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. , 1989, Atherosclerosis.

[3]  K. Barnhart,et al.  The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. , 2000, The Journal of clinical endocrinology and metabolism.

[4]  B. Allolio,et al.  DHEA treatment: myth or reality? , 2002, Trends in Endocrinology & Metabolism.

[5]  H. Weisman,et al.  Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury. , 1988, The Journal of clinical investigation.

[6]  P. Minghetti,et al.  Development of Patches for the Controlled Release of Dehydroepiandrosterone , 2001, Drug development and industrial pharmacy.

[7]  Z. Liu,et al.  Effects of sex hormones on apoptosis in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. , 2001, Chinese Medical Journal.

[8]  S. Crawford,et al.  The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. , 2002, The Journal of clinical endocrinology and metabolism.

[9]  T. Mune,et al.  Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes. , 2003, Endocrinology.

[10]  E. Baulieu,et al.  Dehydroepiandrosterone (DHEA): a fountain of youth? , 1996, The Journal of clinical endocrinology and metabolism.

[11]  B. Bengtsson,et al.  Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. , 2002, The Journal of clinical endocrinology and metabolism.

[12]  L. Garcia-Segura,et al.  Dehydroepiandrosterone regulates insulin-like growth factor-1 system in adult rat hypothalamus , 2002, Endocrine.

[13]  M. Garaulet,et al.  Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. , 2002, The journal of nutrition, health & aging.

[14]  F. Salek,et al.  The Influence of Hormones and Pharmaceutical Agents on DHEA and DHEA‐S Concentrations: A Review of Clinical Studies , 2002, Journal of clinical pharmacology.

[15]  A. M. Linares,et al.  Endogenous concentrations of DHEA and DHEA-S Decrease with remission of depression in older adults , 2001, Biological Psychiatry.

[16]  C. Labrie,et al.  High bioavailability of dehydroepiandrosterone administered percutaneously in the rat. , 1996, The Journal of endocrinology.

[17]  W. Grizzle,et al.  Aging alters zonation in the adrenal cortex of men. , 1997, The Journal of clinical endocrinology and metabolism.

[18]  G. Hammond,et al.  ADRENOCORTICAL FUNCTION IN PUBERTY Serum ACTH, Cortisol and Dehydroepiandrosterone in Girls and Boys , 1979, Acta paediatrica Scandinavica.

[19]  C. Owen,et al.  Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer. , 2002, Current medicinal chemistry.

[20]  S. Wallenstein,et al.  Relationship of endogenous levels of sex hormones to cognition and depression in frail, elderly women. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[21]  D. Cucinotta,et al.  Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. , 2001, European journal of endocrinology.

[22]  E. Engleman,et al.  An open study of dehydroepiandrosterone in systemic lupus erythematosus. , 1994, Arthritis and rheumatism.

[23]  H. Nakagama,et al.  Chemoprevention of precursors to colon cancer by dehydroepiandrosterone (DHEA). , 2002, Life sciences.

[24]  Dehydroepiandrosterone (DHEA) treatment of depression , 1997, Biological Psychiatry.

[25]  Y. Arad,et al.  Dehydroepiandrosterone Feeding Prevents Aortic Fatty Streak Formation and Cholesterol Accumulation in Cholesterol‐fed Rabbit , 1989, Arteriosclerosis.

[26]  W. Mayo,et al.  Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging , 2001, Brain Research Reviews.

[27]  N. Wong,et al.  Effects of dehydroepiandrosterone on rat apolipoprotein AI gene expression in the human hepatoma cell line, HepG2. , 2002, Metabolism: clinical and experimental.

[28]  M. Fassnacht,et al.  Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. , 2001, The Journal of clinical endocrinology and metabolism.

[29]  K. E. Schwartz,et al.  Effects of Oral Prasterone (Dehydroepiandrosterone) on Single‐Dose Pharmacokinetics of Oral Prednisone and Cortisol Suppression in Normal Women , 2001, Journal of clinical pharmacology.

[30]  R. Pommier,et al.  High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy. , 2001, Surgery.

[31]  J. Nolla,et al.  The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus. , 1997, Clinical and experimental rheumatology.

[32]  N. Orentreich,et al.  Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. , 1984, The Journal of clinical endocrinology and metabolism.

[33]  M. Genovese,et al.  A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus , 1999, Lupus.

[34]  B. Allolio,et al.  Dhea Replacement in Women with Adrenal Insufficiency—Pharmacokinetics, Bioconversion and Clinical Effects on Well-Being, Sexuality and Cognition , 2000, Endocrine research.

[35]  F. Silvagno,et al.  Synergistic effect of retinoic acid and dehydroepiandrosterone on differentiation of human neuroblastoma cells , 2002, FEBS letters.

[36]  G. Gordon,et al.  Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  W. Scherbaum,et al.  Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[38]  S. Yen,et al.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. , 1994, The Journal of clinical endocrinology and metabolism.

[39]  J. Souberbielle,et al.  DHEA in bone and joint diseases. , 2001, Joint, bone, spine : revue du rhumatisme.

[40]  T. Pollmächer,et al.  The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. , 2002, The Journal of endocrinology.

[41]  S. Norton,et al.  Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice. , 1997, Autoimmunity.

[42]  E. Baulieu,et al.  AN ADRENAL-SECRETED "ANDROGEN": DEHYDROISOANDROSTERONE SULFATE. ITS METABOLISM AND A TENTATIVE GENERALIZATION ON THE METABOLISM OF OTHER STEROID CONJUGATES IN MAN. , 1965, Recent progress in hormone research.

[43]  E. Barrett-Connor,et al.  A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. , 1986, The New England journal of medicine.

[44]  E. Baulieu,et al.  Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Emans,et al.  Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. , 2002, The Journal of clinical endocrinology and metabolism.

[46]  C. Kirschbaum,et al.  Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. , 1997, The Journal of clinical endocrinology and metabolism.

[47]  C. Labrie,et al.  Intracrinology and The Skin , 2001, Hormone Research in Paediatrics.

[48]  E. Engleman,et al.  Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. , 1998, The Journal of rheumatology.

[49]  B. Yang,et al.  Exogenous dehydroepiandrosterone modified the expression of T helper-related cytokines in NZB/NZW F1 mice. , 1998, Immunological investigations.

[50]  A. Honda,et al.  Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines , 2003, Steroids.

[51]  G. Ceschel,et al.  Skin permeation study of dehydroepiandrosterone (DHEA) compared with its alpha-cyclodextrin complex form. , 2002, Journal of pharmaceutical sciences.

[52]  J. Herbert,et al.  Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone‐induced suppression , 2002, The European journal of neuroscience.

[53]  P. Seed,et al.  Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: a potential contributory factor in steroid-induced osteoporosis. , 2002, Metabolism: clinical and experimental.

[54]  R. Takayanagi,et al.  Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts , 2002, Mechanisms of Ageing and Development.

[55]  Felicia A Huppert,et al.  Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation , 2001, Psychoneuroendocrinology.

[56]  J. Deslypere,et al.  Fat tissue: a steroid reservoir and site of steroid metabolism. , 1985, The Journal of clinical endocrinology and metabolism.

[57]  M. Cascante,et al.  Metabolic Control Analysis Aimed at the Ribose Synthesis Pathways of Tumor Cells: A New Strategy for Antitumor Drug Development , 2004, Molecular Biology Reports.

[58]  M. Racchi,et al.  Dehydroepiandrosterone and the relationship with aging and memory: a possible link with protein kinase C functional machinery , 2001, Brain Research Reviews.

[59]  Abraham Weizman,et al.  Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. , 2003, Archives of general psychiatry.

[60]  F. Labrie,et al.  Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. , 1997, The Journal of clinical endocrinology and metabolism.

[61]  W. Arlt Dehydroepiandrosterone and ageing. , 2004, Best practice & research. Clinical endocrinology & metabolism.

[62]  F. Huppert,et al.  Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. , 2000, The Journal of clinical endocrinology and metabolism.

[63]  O. Wolkowitz,et al.  Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. , 2002, The Journal of clinical endocrinology and metabolism.

[64]  E. Husebye,et al.  Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. , 2003, The Journal of clinical endocrinology and metabolism.

[65]  K. Carlström,et al.  Ovarian Ultrasound and Ovarian and Adrenal Hormones before and after Treatment for Hyperthyroidism , 2002, Gynecologic and Obstetric Investigation.

[66]  G. Gordon,et al.  Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin. , 2001, Anticancer research.

[67]  H. Furusawa,et al.  Accumulation of 4- and 5-ene steroid sulfates in human breast cyst fluids , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[68]  O. Wolkowitz,et al.  Double-blind treatment of major depression with dehydroepiandrosterone. , 1999, The American journal of psychiatry.

[69]  E. Mariani,et al.  Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: results from a cross-sectional Italian study of a general elderly population , 2002, Experimental Gerontology.

[70]  T. Olsson,et al.  Increased Levels of Adrenocortical and Gonadal Hormones in Mild to Moderate Alzheimer’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.

[71]  J. Pepping DHEA: dehydroepiandrosterone. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[72]  S. Luo,et al.  Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. , 2002, Arthritis and rheumatism.

[73]  E. Baulieu,et al.  Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[74]  F. Huppert,et al.  WITHDRAWN: Dehydroepiandrosterone (DHEA) supplementation for cognitive function. , 2007, The Cochrane database of systematic reviews.

[75]  M. Catalano,et al.  Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. , 2002, Endocrinology.

[76]  C. Longcope Dehydroepiandrosterone metabolism. , 1996, The Journal of endocrinology.

[77]  J. Dunn,et al.  Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. , 1981, The Journal of clinical endocrinology and metabolism.

[78]  J. Mckinlay,et al.  Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. , 2001, American journal of epidemiology.

[79]  E. Barrett-Connor,et al.  The Epidemiology of DHEAS and Cardiovascular Disease , 1995, Annals of the New York Academy of Sciences.

[80]  C. Longcope,et al.  Dehydroepiandrosterone metabolism in the female rhesus monkey: Oral versus intravenous administration , 1996, Steroids.

[81]  R. Klein,et al.  Sex Hormones and DHEA-SO4 in Relation to Ischemic Heart Disease Mortality in Diabetic subjects: The Wisconsin Epidemiologic Study of Diabetic Retinopathy , 1996, Diabetes Care.

[82]  K. E. Schwartz,et al.  Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. , 2002, Arthritis and rheumatism.

[83]  K. Esposito,et al.  Cytokine pattern in postmenopause. , 2002, Maturitas.

[84]  E. Engleman,et al.  Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. , 1995, Arthritis and rheumatism.

[85]  A. Root,et al.  Secretion of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities. , 1977, The Journal of pediatrics.

[86]  D. Pepin,et al.  Conversion of dehydroepiandrosterone sulfate at physiological plasma concentration into estrogens in MCF-7 cells , 2002, Steroids.

[87]  T. T. Have,et al.  DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years , 2001, Biological Psychiatry.

[88]  S. Bornstein,et al.  Neuroimmunoregulation of Androgens in the Adrenal Gland and the Skin , 2000, Hormone Research in Paediatrics.

[89]  J. Parasrampuria,et al.  Quality control of dehydroepiandrosterone dietary supplement products. , 1998, JAMA.

[90]  M. Hess,et al.  Dehydroepiandrosterone Inhibits Human Platelet Aggregation in Vitro and in Vivo a , 1995, Annals of the New York Academy of Sciences.

[91]  S. Andò,et al.  The direct proliferative stimulus of dehydroepiandrosterone on MCF7 breast cancer cells is potentiated by overexpression of aromatase , 2001, Molecular and Cellular Endocrinology.